Orthogonalized human protease control of secreted signals
Preprint
Abstract
Synthetic circuits that regulate protein secretion in human cells could support cell-based therapies by enabling control over local environments. While protein-level circuits enable such potential clinical applications, featuring orthogonality and compactness, their non-human origin poses a potential immunogenic risk. Here, we developed Humanized Drug Induced Regulation of Engineered CyTokines (hDIRECT) as a platform to control cytokine activity exclusively using human-derived proteins. We sourced a specific human protease and its FDA-approved inhibitor. We engineered cytokines (IL-2, IL-6, and IL-10) whose activities can be activated and abrogated by proteolytic cleavage. We utilized species specificity and re-localization strategies to orthogonalize the cytokines and protease from the human context that they would be deployed in. hDIRECT should enable local cytokine activation to support a variety of cell-based therapies such as muscle regeneration and cancer immunotherapy. Our work offers a proof of concept for the emerging appreciation of humanization in synthetic biology for human health.Keywords
All Related Versions
- Published version: Nature Chemical Biology, 21 (9), 1351.
This publication has 55 references indexed in Scilit:
- Programmable protein circuit designCell, 2021
- Programmable RNA-Guided RNA Effector Proteins Built from Human PartsCell, 2019
- Skeletal muscle regeneration is modulated by inflammationJournal of Orthopaedic Translation, 2018
- Cytokines in Skeletal Muscle Growth and Decay2017
- Network representations of immune system complexityWIREs Mechanisms of Disease, 2015
- Interleukin-6 and its receptors: A highly regulated and dynamic systemCytokine, 2014
- Interleukin-2 at the Crossroads of Effector Responses, Tolerance, and ImmunotherapyImmunity, 2013
- Plasticity and cross-talk of Interleukin 6-type cytokinesCytokine & Growth Factor Reviews, 2012
- Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle HypertrophyCell Metabolism, 2008
- Replacing the complementarity-determining regions in a human antibody with those from a mouseNature, 1986